Trial reportProceedings of the National Academy of Sciences of the United States of America2018
Enterotoxigenic
Open access · bronzeAbstract readClinical Trial, Phase II
In one paragraph
Trial report in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.
0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed, 79 citations in OpenAlex.
- Emerging and Underdetected Colonization Factors in EnterotoxigenicMicroorganisms · 2026Review
- Evaluation of genomic characteristics of Escherichia coli associated with bovine mastitis and the potential utility of alternative antimicrobial methods.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026Article
- Transcriptomic profiling of a commensal Escherichia coli lysogen in simulated intestinal fluid reveals broad changes in both core and accessory regions of the genome.BMC genomics · 2026Article
- Feeding the invaders: how metabolic imbalance shapes infection and biofilm development.FEMS microbiology reviews · 2026Review
- Integrative phenotypic and functional genomic characterization of virulence and antimicrobial resistance inFrontiers in microbiology · 2026Article
- Fumarate and nitrate reduction regulator (FNR) modulates hypermucoviscosity and virulence in hypervirulentVirulence · 2025Article
- Pathogen virulence genes: Advances, challenges and future directions in infectious disease research (Review).International journal of molecular medicine · 2025Review
- ETEC biofilms are regulated by magnesium and lactate bioavailability.Infection and immunity · 2025Article
- Conventional diagnosis and metagenomic analysis of a novel co-infection case involving Escherichia coli and immunosuppressive conditions with petechial hepatitis of broilers in South Korea: a case report.BMC veterinary research · 2025Article
- Virulence genes and phylogenetic analysis of antibiotic-resistantVeterinary world · 2025Article
- Review
- High Efficacy of Rose Bengal in Reducing the Pathogenicity ofInternational journal of microbiology · 2025Article
- Diverse and specialized metabolic capabilities of microbes in oligotrophic built environments.Microbiome · 2024Article
- Inhibitory Effect ofMicroorganisms · 2024Article
- Current understandings of colibactin regulation.Microbiology (Reading, England) · 2024Review
- Shigella-Controlled Human Infection Models: Current and Future Perspectives.Current topics in microbiology and immunology · 2024Review
- The role of the minor colonization factor CS14 in adherence to intestinal cell models by geographically diverse ETEC isolates.mSphere · 2023Article
- Article
- Immunological pathogenesis of Bovine E. coli infection in a model of C. elegans.BMC microbiology · 2022Article
- Emergence of colistin-resistant hypervirulentEmerging microbes & infections · 2022Article
Corrections and comments
- Commented on by
Authors and funding
17 authors at 5 institutions in 1 country.
Alexander A CroftsDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712.
Simone M GiovanettiDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712.
Erica J RubinDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712.
Frédéric M PolyEnteric Diseases Department, Naval Medical Research Center, Silver Spring, MD 20910.
Ramiro L GutiérrezEnteric Diseases Department, Naval Medical Research Center, Silver Spring, MD 20910.
Kawsar R TalaatDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205.
Chad K PorterEnteric Diseases Department, Naval Medical Research Center, Silver Spring, MD 20910.
Mark S RiddleEnteric Diseases Department, Naval Medical Research Center, Silver Spring, MD 20910.
Barbara DeNearingDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205.
Jessica BrubakerDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205.
Milton MacielImmunology, Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20817.
Ashley N AlcalaEnteric Diseases Department, Naval Medical Research Center, Silver Spring, MD 20910.
Subhra ChakrabortyDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205.
Michael G ProutyEnteric Diseases Department, Naval Medical Research Center, Silver Spring, MD 20910.
Stephen J SavarinoEnteric Diseases Department, Naval Medical Research Center, Silver Spring, MD 20910.
Bryan W DaviesDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712.
M Stephen TrentDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602; strent@uga.edu.ORCID 0000-0001-6134-1800
Naval Medical Research Command · USJohns Hopkins University · USThe University of Texas at Austin · USHenry M. Jackson Foundation · USUniversity of Georgia · US
Funding
MODIFICATION OF HELICOBACTER PYLORI LIPOPOLYSACCHARIDESR01AI064184 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI TRENT, MICHAEL STEPHEN · 2006 to 2015
$3.4MThe Outer Surface of Vibrio CholeraeR01AI076322 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI TRENT, MICHAEL STEPHEN · 2008 to 2017
$3.2MThe Outer Surface of Vibrio choleraeR56AI076322 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI TRENT, MICHAEL STEPHEN · 2013 to 2013
$384kNIAID NIH HHS R01 AI064184NIAID NIH HHS R01 AI076322NIAID NIH HHS R56 AI076322
Abstract
Enterotoxigenic
Indexed as
Gene Expression Regulation, BacterialAdultBiofilmsDiarrheaEnterotoxigenic Escherichia coliEpithelial CellsEscherichia coli InfectionsEscherichia coli ProteinsEscherichia coli VaccinesFemaleHealthy VolunteersHost-Pathogen InteractionsHumansIntestinesIron-Sulfur ProteinsMaleEscherichia coli ProteinsEscherichia coli VaccinesFNR protein, E coliIron-Sulfur ProteinsVirulence Factorscfaenterotoxigenic E. coliETECFNRtoxin
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.